Who makes cardiac output changes with "nor-epinephrine"?

cardiac output changes with "nor-epinephrine" is developed by University Tunis El Manar.

What development phase is cardiac output changes with "nor-epinephrine" in?

cardiac output changes with "nor-epinephrine" is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

cardiac output changes with "nor-epinephrine"

University Tunis El Manar · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	cardiac output changes with "nor-epinephrine"
Also known as	cardiac output: CO (cm3 / min) = ITV * S * HR. ITV (cm) = integral time velocity is measured by pulsed doppler at the level of the ascending aorta, on apical cut.
Sponsor	University Tunis El Manar
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Cardiac Index Changes With Ephedrine, Phenylephrine, Ondansetron and Norepinephrine During Spinal Anesthesia (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

cardiac output changes with "nor-epinephrine" CI brief — competitive landscape report
cardiac output changes with "nor-epinephrine" updates RSS · CI watch RSS
University Tunis El Manar portfolio CI